| |
|
|
|
Vistagen Therap. Com  
|
|
2.41 -0.06 (-0.02%) |
03-01 16:00 |
|
Open: |
2.5633 |
Pre close: |
2.47 |
Target:
|
3.11
|
|
High: |
2.5799 |
Low: |
2.38 |
Resistance:
|
2.66
3.18
|
|
Volume: |
2,539,156 |
Market Cap: |
341M |
Support:
|
1.83
1.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.39
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
2.21  |
Signal(12,26,9): |
0.12 |
|
MA(100): |
1.39 |
Stochastic Oscillator |
%K(14,3):
|
39.51 |
|
MA(250): |
0.89 |
%D(3): |
38.85 |
|
Average Volume(K) |
3-Month: |
432666
|
52-Week |
High:
|
3.18 |
|
10-Days: |
924289 |
Low: |
0.30 |
|
RSI |
RSI(14):
|
55.14 |
Change(%): |
346.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.325 |
Return on Equity (ttm) |
-293.9 |
Shares Out. (M) |
138.54 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-67.4 |
Shares Float (M) |
56.54 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.48 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.53 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5370 |
|
Book Value (p.s.) |
0.060 |
EBITDA (p.s.) |
-0.112 |
P/E |
-7.42 |
|
Sales Per Share |
0.002 |
Qtrly Earnings Growth |
0.00 |
P/BV |
40.17 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.66 |
P/S |
999.64 |
|
Operating Margin |
-4683.14 |
Levered Free Cash Flow
(M) |
-7.36 |
P/CF |
-38.55 |
|
|
|
|
|
|
